Latest filing published 10 Feb 2020 for Diplomat Pharmacy, Inc., €4.7M.
Philip R. Hagerman discloses dealings in Diplomat Pharmacy, Inc. to SEC (Form 4). In total, 70 filings cover trades dated from 9 October 2014 to 10 February 2020.
The open-market record consists of 39 sales worth €228.6M, with no purchase. Outside the open market, there are 3 share grants.
On 10 February 2020 came the latest disclosure, a transaction for €1.1M in Diplomat Pharmacy, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 52 declarations